Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Study II

The breakdown of the perception-related incident errors along with their occurrence percentages were as follows [3,5]  [Pg.83]

Categories of situation awareness errors in offshore drilling incidents and their corresponding occurrence percentages. [Pg.83]


H Kubmyi. Variable selection in QSAR studies. II. A highly efficient combination of systematic search and evolution. Quant Struct-Act Relat 13 393-401, 1994. [Pg.367]

Kennedy, J. P. and Trivedi, P. D. Cationic Olefin Polymerization Using Alkyl Halide — Alkyl-Aluminium Initiator Systems. I. Reactivity Studies. II. Molecular Weight Studies. Vol. 28, pp. 83-151. [Pg.155]

Keeling, C. D. and Bolin, B. (1968). The simultaneous use of chemical tracers in oceanic studies II. A three-reservoir model of the North and South Pacific Oceans. Tellus 20,17-54. [Pg.315]

Zaykin DV, Young SS. Large recursive partitioning analysis of complex disease pharmacogenetic studies. II. Statistical considerations. Pharmacogenomics 2005 6(l) 77-89. [Pg.441]

Poulin P, Theil FP. Prediction of pharmacokinetics prior to in vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition. J Pharm Sci 2002 May 91(5) 1358-70. [Pg.551]

Haug, A.J. "Guar Mannogalactan Studies II. Effect of Certain Variables, Including Borax, on the Rate of Oxidation of the Purified Mucilage," TAPPI. Vol. 36, No. 1, January 1953, 53 62. [Pg.672]

Partali, V., Liaaen-Jensen, S., Slagsvold, T., and Lifjeld, J. T. 1987. Carotenoids in food chain studies. II. The food chain of Pams spp. monitored by carotenoid analysis. Comp. Biochem. Physiol. B 87 885-888. [Pg.509]

Classic Papers in Chemistry S. P. L. Sorenson, Enzyme Studies II. The Measurement and Meaning of Hydrogen Ion Concentration in Enzymatic Processes. Biochemische Zeitschrift 21, (1909) 131-200,... [Pg.73]

P. J. Niebergall, G. Milsovich, J. E. Goyan. Dissolution rate studies. II. Dissolution of particles under conditions of rapid agitation. J. Pharm. Sci. 1963, 52, 236-241. [Pg.211]

Fuger, J. (1961). Actinide and lanthanide ion exchange separation studies. II. Separation by aminopolyacetic acids, J. Inorg. Nucl. Chem. 18, 263. [Pg.84]

Aakrog A (1975) Reference methods of marine radioactivity studies II. Technical report services no. 169. IAEA, Vienna, Austria... [Pg.361]

Sorenson SPL. Enzyme studies II. The measurement and meaning of hydrogen ion concentrations in enzymatic processes. Biochem. Z. 1909 21 131-200. [Pg.34]

For interlaboratory study II, each participant received three cartridges spiked with water matrices containing different levels of surfactants, and three solutions of analytes. The cartridges were prepared as follows ... [Pg.540]

This interlaboratory study was conducted in the same manner as interlaboratory study II, but at lower concentration levels for both... [Pg.540]

The results of interlaboratory study II are presented in Fig. 4.5.1. Five sets of results were obtained for the LAS exercise, and four sets for the NPEO exercise. For LAS, the within-laboratory variability ranged between 2 and 8% (RSD) for sample III (distilled water spiked with lmgL-1 LAS), 1 and 13% for sample 112 (wastewater influent), and 3 and 8% for sample 113 (sample 112 spiked with lmgL-1 LAS). Between-laboratory variations (calculated from the mean of laboratory means, MOLM) amounted to RSDs of 15, 30 and 30% for samples III, 112 and 113, respectively. The LAS values reported were in the range of 700—1100 p,g L-1 in sample III, 1100-1800 p,g L-1 in sample 112 and 1900-3000 p,g L-1 in sample 113, indicating that even in the matrix wastewater influent, the spiked concentration of lmgL-1 LAS could be almost quantitatively determined by all laboratories. [Pg.544]

Fig. 4.5.1. Laboratory means, mean of laboratory means (MOLM) and mean of all reported values (MOAV) from interlaboratory study II. (A) LAS, cartridge III (B) LAS, cartridge 112 (C) LAS, cartridge 113 (D) NPEO, cartridge III (E) NPEO, cartridge 112 ... Fig. 4.5.1. Laboratory means, mean of laboratory means (MOLM) and mean of all reported values (MOAV) from interlaboratory study II. (A) LAS, cartridge III (B) LAS, cartridge 112 (C) LAS, cartridge 113 (D) NPEO, cartridge III (E) NPEO, cartridge 112 ...
Foster Wheeler. 2001. Supercritical Water Oxidation (SCWO) Engineering Design Studies II—TW—SCWO GB Campaign Operability Draft Test Report, December 31. Livingston, N.J. Foster Wheeler Development Corporation. [Pg.153]

Case Study II). Transfer of a Drug Product Dissouution Method (HPLC/UV Detection)... [Pg.33]

R. L. Bronaugh, R. E Stewart, and E. R. Congdon. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol. 62 481 188 (1982). [Pg.25]

Sciuto P. F. and Ottonello G. (1995b). Water-rock interaction on Zabargad Island (Red Sea)., a case study II). from local equilibrium to irreversible exchanges. Geochim. Cosmochim. Acta, 59 2207-2214. [Pg.853]

Gaffney PE. 1976. Carpet and rug industry case study II Biological effects. J Water Pollut Contr Fed 48 2731-2737. [Pg.250]

Tabershaw IR, Kleinfeld M Manufacture of tricresyl phosphate and other alkyl phenyl phosphates An industrial hygiene study. II. Clinical effects of tricresyl phosphate. AMA Arch Ind Health 14 541-544, 1957... [Pg.717]

O—N bond is cleaved, maintaining, for convenience, the previous model. For a given sequence XYZ, the results will be presented in order of decreasing reactivity, 1,2,4-oxadiazole, isoxazole, 1,2,5-oxadiazole, quoting the heterocycle only when new examples are discussed. The results of photochemical (II, A, 10) and mechanistic studies (II,B) will be presented in special sections. Rearrangements involving the cleavage of an N—N bond will be discussed separately (Section II,C). [Pg.52]

Boecker BB, Thomas RG, Scott JK. 1963. Thorium distribution and excretion studies. II. General patterns following inhalation and the effect of the size of the inhaled dose. Health Phys 9 165-176. [Pg.133]

CIBIS II Investigators and Committee. The cardiac insufficiency bisoprolol study II (CIBIS-II) a randomised trial. Lancet 1999 353 9-13. [Pg.63]

Leape LL, Brennan TA, Laird N, Lawthers AG, Localio AR, Barnes BA et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991 324(6) 377-84. [Pg.241]

EuKng S et al (2011) Use of genomic data in risk assessment case study II. Evaluation of the dibutyl phthalate toxicogenomic data set. Toxicol Appl Pharmacol. doi S0041-008X(ll)00236-5 (pii)I0.I0I6/j.taap. 2011.06.014... [Pg.472]

The high MIBK selectivity over the palladium catalysts suggested that the hydrogenation of MO was facile and that the overall rate-determining step may lie in the aldol part of the sequence rather than with the hydrogenation. If this was the case the case then we may have expected to have similar activation energies for the formation of MO and MIBK. In a previous study (II) an activation energy of 23+4 kj.mof was calculated for the formation of MO from... [Pg.72]


See other pages where Study II is mentioned: [Pg.271]    [Pg.57]    [Pg.690]    [Pg.269]    [Pg.266]    [Pg.247]    [Pg.72]    [Pg.562]    [Pg.121]    [Pg.121]    [Pg.122]    [Pg.540]    [Pg.544]    [Pg.508]    [Pg.64]    [Pg.37]    [Pg.329]    [Pg.640]   


SEARCH



Case Study II Heterogeneously Catalyzed Hydrogenation of Hexene

Case Study II Poly-Si Surface Micromachining and Angular Rate Sensor

Designing for Biodegradation II Biocides Case Study

FT-IR and ESR studies on Cu(II)-loaded microspheres

Level I, II, and III Epidemiological Studies

NMR Studies on Mononuclear Type II Copper-Containing Proteins

Oslo II study

Phase I/II studies

Phase II clinical studies

Phase II studies

Phase II/III studies

Segment II study

Studies of Cobalt(II) Compounds

Studies of Mn(II)

Study II VDF Precipitation Polymerization

Type II Chaperonins and Early Functional Studies

© 2024 chempedia.info